Format

Send to

Choose Destination
See comment in PubMed Commons below
J Infect Dis. 2013 Sep;208(6):1026-33. doi: 10.1093/infdis/jit273. Epub 2013 Jun 17.

Reduced risk of disease during postsecondary dengue virus infections.

Author information

1
Department of Entomology, University of California, Davis 95616, USA. smolkowski@ucdavis.edu

Abstract

BACKGROUND:

Antibodies induced by infection with any 1 of 4 dengue virus (DENV) serotypes (DENV-1-4) may influence the clinical outcome of subsequent heterologous infections. To quantify potential cross-protective effects, we estimated disease risk as a function of DENV infection, using data from longitudinal studies performed from September 2006 through February 2011 in Iquitos, Peru, during periods of DENV-3 and DENV-4 transmission.

METHODS:

DENV infections before and during the study period were determined by analysis of serial serum samples with virus neutralization tests. Third and fourth infections were classified as postsecondary infections. Dengue fever cases were detected by door-to-door surveillance for acute febrile illness.

RESULTS:

Among susceptible participants, 39% (420/1077) and 53% (1595/2997) seroconverted to DENV-3 and DENV-4, respectively. Disease was detected in 7% of DENV-3 infections and 10% of DENV-4 infections. Disease during postsecondary infections was reduced by 93% for DENV-3 and 64% for DENV-4, compared with primary and secondary infections. Despite lower disease rates, postsecondary infections constituted a significant proportion of apparent infections (14% [for DENV-3 infections], 45% [for DENV-4 infections]).

CONCLUSIONS:

Preexisting heterotypic antibodies markedly reduced but did not eliminate the risk of disease in this study population. These results improve understanding of how preinfection history can be associated with dengue outcomes and DENV transmission dynamics.

KEYWORDS:

antibody cross-protection; dengue; dengue fever; seroepidemiology

PMID:
23776195
PMCID:
PMC3749012
DOI:
10.1093/infdis/jit273
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Support Center